Compare
Envoy Medical, Inc. vs Safe Pro Group Inc. vs Anteris Technologies Global Corp. vs NutriBand Inc.
| Latest fiscal year | Envoy Medical, Inc. COCH | Safe Pro Group Inc. SPAI | Anteris Technologies Global Corp. AVR | NutriBand Inc. NTRB |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-01-31 |
| Revenue | $241.0K | $606.7K | $1.91M | $2.04M |
| Revenue growth (YoY) | +7.1% | -72.0% | -29.2% | -4.8% |
| Gross margin | -262.7% (computed) | 33.3% | 70.3% (computed) | 27.8% (computed) |
| Operating margin | n/m | n/m | n/m | -408.4% |
| Net margin | n/m | n/m | n/m | -404.1% |
| Net income | -$23.76M | -$14.32M | -$94.14M | -$8.23M |
| EPS (Diluted) | -$1.23 | -$0.85 | -$2.55 | -$2.58 |
| Operating cash flow | -$18.20M | -$6.22M | -$77.80M | -$5.13M |
| Free cash flow | -$18.38M | -$6.27M | -$79.76M | -$5.14M |
| Cash & equivalents | n/a | n/a | n/a | $4.57M |
| Total assets | $8.56M | $19.11M | $23.00M | $7.55M |
| Total liabilities | $20.32M | $1.40M | $23.25M | $868.4K |
| Shareholders' equity | -$12.16M | $17.72M | -$93.0K | $6.68M |
| Return on year-end equity | n/a | -80.8% | n/a | -123.2% |
| Shares outstanding | n/a | 20.74M | 41.58M | 12.16M |
Revenue, most recent five fiscal years
| Fiscal year | Envoy Medical, Inc. | Safe Pro Group Inc. | Anteris Technologies Global Corp. | NutriBand Inc. |
|---|---|---|---|---|
| Latest | $241.0K Ended 2025-12-31 | $606.7K Ended 2025-12-31 | $1.91M Ended 2025-12-31 | $2.04M Ended 2026-01-31 |
| 1 year earlier | $225.0K Ended 2024-12-31 | $2.17M Ended 2024-12-31 | $2.70M Ended 2024-12-31 | $2.14M Ended 2025-01-31 |
| 2 years earlier | $316.0K Ended 2023-12-31 | $917.7K Ended 2023-12-31 | n/a | $2.09M Ended 2024-01-31 |
| 3 years earlier | $237.0K Ended 2022-12-31 | n/a | n/a | $2.08M Ended 2023-01-31 |
| 4 years earlier | n/a | n/a | n/a | $1.42M Ended 2022-01-31 |